Neogen (NEOG) Cash from Financing Activities (2010 - 2026)
Neogen (NEOG) posted quarterly Cash from Financing Activities of -$300000.0 for Q2 2026, up 85.71% year-over-year from -$161538.5 in Q2 2025, and down 140.32% quarter-over-quarter from $744000.0 in Q1 2026.
Neogen (NEOG) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Neogen's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$300000.0 for Q2 2026.
- In Q2 2026, Cash from Financing Activities rose 85.71% year-over-year to -$300000.0; the TTM figure through May 2026 stood at -$99.4 million (down 6112.5% YoY), while the FY2026 annual figure was -$99.4 million, down 6112.5% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$300000.0, down from $744000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $1.2 million in Q1 2024, with the low at -$99.4 million in Q3 2025.
- The 5-year median for Cash from Financing Activities is -$199500.0 (2024), against an average of -$12.1 million.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 124.49% in 2023, then plunged 10252.5% in 2025.
- Neogen's Cash from Financing Activities stood at -$79.3 million in 2022, then jumped by 99.61% to -$310000.0 in 2023, then sank by 354.52% to -$1.4 million in 2024, then soared by 67.99% to -$451000.0 in 2025, then jumped by 33.48% to -$300000.0 in 2026.
- Business Quant data shows NEOG's Cash from Financing Activities at -$300000.0 in Q2 2026, $744000.0 in Q1 2026, and -$451000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | -300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -300,000.00 |
| May 31, 2026 | -300,000.00 |
| Feb 28, 2026 | 744,000.00 |
| Feb 28, 2026 | 744,000.00 |
| Nov 30, 2025 | -451,000.00 |
| Nov 30, 2025 | -451,000.00 |
| Aug 31, 2025 | -99.39 Mn |
| Aug 31, 2025 | -99.39 Mn |
| May 31, 2025 | -2.10 Mn |
| May 31, 2025 | -2.10 Mn |
| Feb 28, 2025 | 930,000.00 |
| Feb 28, 2025 | 930,000.00 |
| Nov 30, 2024 | -1.41 Mn |
| Nov 30, 2024 | -1.41 Mn |
| Aug 31, 2024 | 979,000.00 |
| Aug 31, 2024 | 979,000.00 |
| May 31, 2024 | -81,000.00 |
| May 31, 2024 | -81,000.00 |
| Feb 29, 2024 | 1.25 Mn |
| Feb 29, 2024 | 1.25 Mn |